Westborough, MA, United States of America

Huawei Qiu

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 139(Granted Patents)


Location History:

  • Framingham, MA (US) (2016)
  • Cambridge, MA (US) (2017)
  • Westborough, MA (US) (2009 - 2024)
  • Bridgewater, NJ (US) (2017 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibody-Drug Conjugation
Trispecific Binding Proteins
Tumor-Specific Linkers
Anti-TGF-Beta Antibodies
Site-Specific Glycoengineering
Hyperglycosylated Polypeptides
Bone-Targeting Antibodies
Anti-CHIKV Antibodies
Modified-IgG Antibodies
Cytokine Polypeptides
Nucleotide Sequences
VEGF Antagonist Compositions
43 patents (USPTO):Explore Patents

Title: Innovations of Huawei Qiu: Pioneering Therapeutics with a Patent Portfolio of 42

Introduction

Huawei Qiu is a prominent inventor located in Westborough, MA, with an impressive portfolio of 42 patents. His inventive work primarily focuses on advanced therapeutics that target cancer cells and enhance the efficacy of medical treatments.

Latest Patents

Among his latest innovations, Qiu has developed tumor-specific cleavable linkers. This technology provides an innovative approach for delivering drugs and prodrugs specifically to tumor cell environments. The disclosure also includes the cleavage products of these drugs and prodrugs, along with various methods for their application.

Another significant patent includes trispecific binding proteins, which are designed with four polypeptide chains that create three antigen binding sites. These binding proteins have the capability to attach to various target proteins, providing multiple avenues for therapeutic intervention. Notably, one embodiment targets CD28, CD3, and tumor proteins, while another version aims at HIV target proteins. The associated methods for producing trispecific and/or trivalent binding proteins mark a notable advancement in the field.

Career Highlights

Huawei Qiu has made significant contributions during his tenure at leading companies, including Genzyme Corporation and Sanofi. His innovative work has propelled advancements in the pharmaceuticals and biotechnology sectors, solidifying his reputation as a leading figure in the field.

Collaborations

Throughout his career, Qiu has worked alongside distinguished colleagues, including Clark Qun Pan and James E Stefano. This collaboration with other experts reflects his dedication to pioneering research and innovation in therapeutics.

Conclusion

In summary, Huawei Qiu is a remarkable inventor whose contributions to patented technologies have opened new avenues in cancer treatment and other medical fields. His profound expertise paired with strategic collaborations continues to make a significant impact on the development of innovative therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…